Cargando…
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
A thorough interrogation of the immune landscape is crucial for immunotherapy strategy selection and prediction of clinical responses in non-small-cell lung cancer (NSCLC) patients. Single-cell RNA sequencing (scRNA-seq) techniques have prompted the opportunity to dissect the distinct immune signatu...
Autores principales: | Wang, Chengdi, Yu, Qiuxiao, Song, Tingting, Wang, Zhoufeng, Song, Lujia, Yang, Ying, Shao, Jun, Li, Jingwei, Ni, Yinyun, Chao, Ningning, Zhang, Li, Li, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411197/ https://www.ncbi.nlm.nih.gov/pubmed/36008393 http://dx.doi.org/10.1038/s41392-022-01130-8 |
Ejemplares similares
-
A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patients
por: Shao, Jun, et al.
Publicado: (2020) -
The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
por: Wang, Chengdi, et al.
Publicado: (2021) -
Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer
por: Zhang, Li, et al.
Publicado: (2022) -
Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing
por: Wang, Zhoufeng, et al.
Publicado: (2021) -
The number of brain metastases predicts the survival of non‐small cell lung cancer patients with EGFR mutation status
por: Shao, Jun, et al.
Publicado: (2021)